The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCAT 2024 | Improving outcomes of bone marrow transplantation in pediatric patients
In this video, Jean-Hugues Dalle, MD, PhD, Université Paris Cité, Paris, France, outlines some key discussion points from a session on bone marrow transplantation in pediatric patients. Prof. Dalle highlights the importance of adequately preparing the patient prior to transplant to ensure the best possible outcome. This interview took place at the 19th Annual Scientific Conference of the Academy for Sickle Cell and Thalassaemia (ASCAT 2024) in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Advisory board: Vertex.
